We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

6 hedge funds and large institutions have $841K invested in TriSalus Life Sciences Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 5 → 6 (+1)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$38

Top Sellers

No sellers this quarter

TLSIW Hedge Fund Activity: Q3 2026 in Review

6 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2026, worth a combined $841K — up 5.3% from $798K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TLSIW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $38.

  • 6 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2026, up from 5 in Q2 2026.
  • Funds reported $841K of TriSalus Life Sciences Warrant stock for Q3 2026, up 5.3% quarter-over-quarter.
  • 1 fund opened new TriSalus Life Sciences Warrant positions in Q3 2026 and 0 closed out, a net change of +1 holder.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2026 was Tower Research Capital (TRC), an estimated $38 added.

Based on aggregated 13F filings for Q3 2026.